Table 4.
ORs for the severity of ACS by quartiles of Hsp70 and anti-Hsp70 antibody levels
| Quartile | P trend | ||||
|---|---|---|---|---|---|
| 1st | 2nd | 3rd | 4th | ||
| Hsp70 | |||||
| Range, ng/mL | <0.91 | ≥0.91 to <2.36 | ≥0.91 to < 4.39 | ≥4.39 | |
| 1-disease vessel/≥2-diseased vessels | 25/31 | 17/34 | 21/62 | 19/82 | |
| Crude (95% CI) | 1.00 | 1.61 (0.74-3.54) | 2.46 (1.19-5.06) | 3.40 (1.64-7.02) | 0.001 |
| Adjusted ORa (95% CI) | 1.00 | 1.36 (0.58-3.18) | 2.35 (1.08-5.13) | 3.51 (1.58-7.79) | 0.001 |
| Anti-Hsp70 antibody | |||||
| Range, μg/mL | <200.21 | ≥200.21 to <275.26 | ≥275.26 to < 413.24 | ≥413.24 | |
| 1 disease vessel/≥2 diseased vessels | 24/68 | 22/56 | 22/36 | 14/49 | |
| Crude (95% CI) | 1.00 | 0.97 (0.49-1.90) | 0.61 (0.30-1.22) | 1.22 (0.57-2.58) | 0.955 |
| Adjusted ORa (95% CI) | 1.00 | 1.20 (0.57-2.52) | 0.61 (0.29-1.28) | 1.19 (0.54-2.63) | 0.972 |
aAdjusted for age, sex, smoking, BMI, hypercholesterolemia, hypertension, diabetes and family history of CHD.